Suvaxyn CSF Marker

RSS

classical swine fever vaccine (live recombinant)

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report. Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This document cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 05/04/2017

Authorisation details

Product details
Name
Suvaxyn CSF Marker
Agency product number
EMEA/V/C/002757
Active substance
live Recombinant E2 gene deleted Bovine Viral Diarrhoea Virus containing Classical Swine Fever E2 (CP7_E2alf)
International non-proprietary name (INN) or common name
classical swine fever vaccine (live recombinant)
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI09AD04
Publication details
Marketing-authorisation holder
Zoetis Belgium SA
Revision
2
Date of issue of marketing authorisation valid throughout the European Union
10/02/2015
Contact address
Rue Laid Burnait, 1
1348 Louvain-la-Neuve
Belgium

Product information

23/03/2017 Suvaxyn CSF Marker - EMEA/V/C/002757 - IG/0747 (0004)

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Lyophilisate and solvent for suspension for injection

Therapeutic indication

For active immunisation of pigs from 7 weeks of age onwards to prevent mortality and reduce infection and disease caused by classical swine fever virus (CSFV).

Onset of immunity: 14 days.

Duration of immunity: at least 6 months.

Assessment history

How useful was this page?

Add your rating